Ventsislav Dobrev

Ventsislav Dobrev currently serves as the Global Clinical Integration Lead for Digital Biomarkers at Roche, where responsibilities include establishing digital health solutions for clinical trials and integrating mobile sensor data into clinical development processes. Dobrev also holds positions as a member and angel investor in Swiss Health Angels and MEDKAP Investor Association, and serves on the advisory board for Menken Trials and FindMeCure. Previously, Dobrev was the Global Lead of Digital Health at Ypsomed AG, CEO of Cardio & diaBetter e-Health, and held various leadership roles at Novartis, including Business & Digital Strategy and General Manager of the Oncology division in Bulgaria. Educational qualifications include a Master of Advanced Studies in Digital Health from ETH Zürich, a Master's thesis in Neuropharmacology from Vrije Universiteit Brussel, a Master's degree in Pharmacy from Medical University - Sofia, and an MBA from Sofia University St. Kliment Ohridski.